Optimizing therapy in patients with pancolitis (Q36270395)

13 August 2017

1 reference

title

Optimizing therapy in patients with pancolitis (English)

1 reference

13 August 2017

Gary R Lichtenstein

1 reference

13 August 2017

Carmen Cuffari

1 reference

13 August 2017

Daniel H Present

series ordinal

1 reference

13 August 2017

Theodore M Bayless

series ordinal

1 reference

13 August 2017

publication date

1 October 2005

1 reference

Inflammatory Bowel Diseases

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

937-946

1 reference

Changes in extent of ulcerative colitis: a study on the course and prognostic factors

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Ulcerative colitis and colorectal cancer. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Inflammatory bowel disease. Part II: Clinical and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

High-density oral barium sulfate in abdominal MRI: efficacy and tolerance in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Review article: Oral, modified-release mesalazine formulations--proprietary versus generic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Use of laboratory testing to guide 6-mercaptopurine/azathioprine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Medical therapy of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis: a cross-sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Colonoscopic surveillance for cancer in ulcerative colitis: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Clinical outcome of ulcerative colitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

21 January 2018

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Cancer risk in ulcerative colitis: surveillance or surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Colonic dysplasia and cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Colorectal cancer prevention in ulcerative colitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

Aminosalicylates: potential antineoplastic actions in colon cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.MIB.0000179469.86500.AC

10.1097/01.MIB.0000179469.86500.AC

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference